- Home
- LPRO vs OSUR Comparison
LPRO vs OSUR Comparison
Compare LPRO & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPRO
- OSUR
- Stock Information
- Founded
- LPRO 2000
- OSUR 2000
- Country
- LPRO United States
- OSUR United States
- Employees
- LPRO N/A
- OSUR N/A
- Industry
- LPRO Finance: Consumer Services
- OSUR Medical/Dental Instruments
- Sector
- LPRO Finance
- OSUR Health Care
- Exchange
- LPRO Nasdaq
- OSUR Nasdaq
- Market Cap
- LPRO 232.4M
- OSUR 228.1M
- IPO Year
- LPRO N/A
- OSUR 1986
- Fundamental
- Price
- LPRO $2.50
- OSUR $3.08
- Analyst Decision
- LPRO Buy
- OSUR Hold
- Analyst Count
- LPRO 6
- OSUR 1
- Target Price
- LPRO $3.44
- OSUR $3.00
- AVG Volume (30 Days)
- LPRO 1.2M
- OSUR 853.7K
- Earning Date
- LPRO 08-07-2025
- OSUR 08-05-2025
- Dividend Yield
- LPRO N/A
- OSUR N/A
- EPS Growth
- LPRO N/A
- OSUR N/A
- EPS
- LPRO N/A
- OSUR N/A
- Revenue
- LPRO $17,672,000.00
- OSUR $161,626,000.00
- Revenue This Year
- LPRO $314.67
- OSUR N/A
- Revenue Next Year
- LPRO $15.32
- OSUR $6.80
- P/E Ratio
- LPRO N/A
- OSUR N/A
- Revenue Growth
- LPRO N/A
- OSUR N/A
- 52 Week Low
- LPRO $0.70
- OSUR $2.36
- 52 Week High
- LPRO $6.92
- OSUR $4.92
- Technical
- Relative Strength Index (RSI)
- LPRO 66.93
- OSUR 63.30
- Support Level
- LPRO $2.36
- OSUR $3.00
- Resistance Level
- LPRO $2.56
- OSUR $3.13
- Average True Range (ATR)
- LPRO 0.15
- OSUR 0.12
- MACD
- LPRO 0.04
- OSUR 0.01
- Stochastic Oscillator
- LPRO 91.97
- OSUR 100.00
About LPRO Open Lending Corporation
Open Lending Corp is engaged in providing automated lending services to financial institutions. The company offers loan analytics, risk-based pricing, risk modeling, and automated decision technology. Its Lenders Protection Program ("LPP") enables automotive lenders to make loans that are largely insured against, losses from defaults.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.